Beijing Innova Medicine Technology Co., Ltd.
PrivateLast Round
Strategic
Mar 26, 2026
Total Funding Raised
$97.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Beijing Innova Medicine Technology Co., Ltd. is a biotechnology company that develops innovative medicines using a nano-delivery platform technology for the treatment of atherosclerosis-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Innova Medicine Technology Co., Ltd. Comparables
Compare Beijing Innova Medicine Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyclarity Therapeutics | 86% | |
| Repair Biotechnologies | 77% | |
| Verve | 69% |
Beijing Innova Medicine Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 26, 2026 | ||||
| Series D | Oct 19, 2025 | ||||
| Strategic | Jun 27, 2024 | ||||
| Series C | Jul 1, 2023 | ||||
| Pre Seed | Sep 27, 2019 |
Beijing Innova Medicine Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series C, Series B |
| Hunan Xingxiang Capital Management | Series C, Series B |
| Wuhan Industrial Innovation and Development Research Institute | Strategic |
| 合肥市建设投资控股（集团）有限公司 | Series D |
| Xingtai Capital Management | Series D |
| China Science and Technology Industry Investment Management | Series D |
| CAS Star | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
Led by Renhe Capital.
- Oct 19, 2025
Raised Series D with investors including China Science and Technology Industry Investment Management.
Beijing Innova Medicine Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Innova Medicine Technology Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Innova Medicine Technology Co., Ltd. a public or private company?
Beijing Innova Medicine Technology Co., Ltd. is a private company.
What is the current stock price of Beijing Innova Medicine Technology Co., Ltd.?
Beijing Innova Medicine Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Beijing Innova Medicine Technology Co., Ltd. worth (valuation)?
Valuation information for Beijing Innova Medicine Technology Co., Ltd. is not publicly available.
Can I buy Beijing Innova Medicine Technology Co., Ltd. stock?
Beijing Innova Medicine Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Innova Medicine Technology Co., Ltd.'s last funding round?
Funding round information for Beijing Innova Medicine Technology Co., Ltd. is not publicly available.
Who are the main investors in Beijing Innova Medicine Technology Co., Ltd.?
Investor information for Beijing Innova Medicine Technology Co., Ltd. is not publicly disclosed.
Will Beijing Innova Medicine Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Innova Medicine Technology Co., Ltd..
How can I track Beijing Innova Medicine Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Innova Medicine Technology Co., Ltd.'s secondary market activity and sign up for updates.